RAPT Therapeutics Inc (RAPT NASDAQ) stock market data APIs
$35.1494
-3.29(-9.4%)
as of January 16, 2026
Try our APIs with
free plan!
RAPT Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Prev. Close
35.1494
Open
31.864
High
35.21
Low
31.7834
52 wk Range
5.664-42.392
Market Cap
973 M
Shares Outstanding
27 711 K
EPS
-0.65
Beta
0.462
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with RAPT Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get RAPT Therapeutics Inc data using free add-ons & libraries
Get RAPT Therapeutics Inc Fundamental Data
RAPT Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -111 664 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-06
- EPS/Forecast: -0.1085
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
RAPT Therapeutics Inc News
New
Stocks Tumble as Greenland Crisis Sparks Risk-Off in Asset Markets
The S&P 500 Index ($SPX) (SPY) today is down -1.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -1.22%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.41%. March E-mini S&P futures...
Stocks to Watch Tuesday: 3M, Nvidia, Netflix, Warner Bros.
↗️ Nvidia (NVDA) and Alphabet (GOOGL, GOOG): Chip stocks and other big technology names were among the biggest fallers Tuesday morning as equities around the world sold off. ↘️ 3M (MMM): The P...
Stock market today: Dow, S&P 500, Nasdaq sink as Trump tariff threats and bond sell-off rattle nerves
US stocks posted hefty losses early Tuesday after President Trump reignited trade-war tensions with Europe over Greenland, while a Japan-led global bond sell-off reverberated through markets. The Dow...
Traders Digest Trump's Greenland Demands, US Equity Futures Down Pre-Bell
US equity futures were down ahead of Tuesday's opening bell after President Donald Trump threatened PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
